Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Publication exchanges : Amex save search
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
ANVS | $12.74 7.24% 0.0% 430K
|
Health Technology
|
| O: -0.66%
H: 3.67%
C: -0.33%
publication
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2023
Published: 2024-03-27 (Crawled : 21:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: 2.64%
H: 0.31%
C: -1.5%
energy year publication financial
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Published: 2024-03-14 (Crawled : 12:00) - biospace.com/
ZOM | $0.1302 -0.84% 0.92% 2.5M
|
Miscellaneous
|
| O: -4.89%
H: 2.87%
C: 1.66%
test diagnostic publication research platform
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Nine Month Periods Ended September 30, 2023
Published: 2023-12-11 (Crawled : 22:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: 0.86%
H: 2.79%
C: 2.79%
energy publication financial
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
Published: 2023-09-08 (Crawled : 12:30) - globenewswire.com
CRMD | $5.33 -2.2% -2.06% 420K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -1.6%
it-100 publication study
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Six Month Periods Ended June 30, 2023
Published: 2023-08-24 (Crawled : 22:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: 0.74%
H: 3.46%
C: 3.46%
energy six publication financial
Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases
Published: 2023-08-22 (Crawled : 12:00) - globenewswire.com
MTNB | $0.1818 0.17% 2.04% 520K
|
Health Technology
|
| O: 21.95%
H: 0.0%
C: -19.9%
mat2203 publication biopharma trial results
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three Months Ended March 31, 2023
Published: 2023-05-31 (Crawled : 21:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: -4.76%
H: 2.5%
C: 2.5%
energy publication financial
Caledonia Mining Corporation Plc - Correction to announcement regarding publication of Annual Report on Form 20-F exhibiting Technical Report Summaries
Published: 2023-04-28 (Crawled : 15:00) - globenewswire.com
CMCL | $10.03 -0.99% 0.0% 92K
|
Non-Energy Minerals
|
| O: -0.07%
H: 2.3%
C: 2.23%
announcement report corporation publication mining
Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer
Published: 2023-04-07 (Crawled : 13:00) - globenewswire.com
OCX | News | $2.46 0.2% -6.74% 40K
|
Health Technology
| Email alert
Add to watchlist
cancer publication results study
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2022
Published: 2023-03-29 (Crawled : 21:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: 4.8%
H: 7.47%
C: 2.49%
energy year publication financial
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology
Published: 2023-03-20 (Crawled : 13:20) - biospace.com/
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 3.19%
H: 1.16%
C: -9.27%
control publication pharmaceuticals study
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Nine Month Periods Ended September 30, 2022
Published: 2022-11-30 (Crawled : 22:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
|
| O: -1.84%
H: 4.62%
C: 0.54%
energy financial publication
Palatin Announces Publication of Vyleesi® (bremelanotide) fMRI Study in Women with Hypoactive Sexual Desire Disorder (HSDD)
Published: 2022-10-17 (Crawled : 12:00) - prnewswire.com
PTN | $1.73 -1.14% 0.0% 61K
|
Health Technology
|
| O: 1.94%
H: 1.14%
C: -4.19%
vyleesi women publication study
Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer's Disease
Published: 2022-10-11 (Crawled : 12:00) - prnewswire.com
ANVS | $12.74 7.24% 0.0% 430K
|
Health Technology
|
| O: -0.4%
H: 2.96%
C: 0.96%
disease alzheimer's publication phase 2b
Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington's Disease and Prion Diseases
Published: 2022-09-13 (Crawled : 12:00) - prnewswire.com
ANVS | $12.74 7.24% 0.0% 430K
|
Health Technology
|
| O: -7.57%
H: 20.09%
C: 11.9%
treatment disease publication huntington’s disease
Timber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of Dermatology
Published: 2022-08-26 (Crawled : 13:00) - biospace.com/
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 2.33%
H: 3.98%
C: -3.57%
tmb-001 control therapy results publication study phase 2b
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Six Month Periods Ended June 30, 2022
Published: 2022-08-25 (Crawled : 22:00) - prnewswire.com
ELLO | $14.8 -2.38% 0.0% 2.4K
|
Utilities
| Email alert
Add to watchlist
energy six publication
Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer
Published: 2022-08-24 (Crawled : 12:20) - globenewswire.com
OCX | News | $2.46 0.2% -6.74% 40K
|
Health Technology
|
| O: -1.09%
H: 3.44%
C: 1.94%
response bladder therapy cancer publication
BiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Disease
Published: 2022-08-04 (Crawled : 16:00) - biospace.com/
PHGE | $0.3399 -1.91% 0.0% 130K
|
Health Technology
|
| O: 5.95%
H: 16.37%
C: 0.22%
treatment research disease preclinical publication
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.